An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Dorado P, Machín E, de Andrés F, Naranjo ME, Peñas-Lledó EM, Llerena A; CEIBA.FP Consortium for the Ibero-American Network of Pharmacogenomics RIBEF.Dorado P, et al. Among authors: de andres f.Drug Metabol Drug Interact. 2012;27(4):217-33. doi: 10.1515/dmdi-2012-0018.Drug Metabol Drug Interact. 2012.PMID: 23093260
Dorado P, de Andrés F, Naranjo ME, Peñas-Lledó EM, González I, González AP, de la Rubia A, Llerena A.Dorado P, et al. Among authors: de la rubia a, de andres f.Drug Metabol Drug Interact. 2012;27(3):165-70. doi: 10.1515/dmdi-2012-0016.Drug Metabol Drug Interact. 2012.PMID: 23089607Clinical Trial.
de Andrés F, Sosa-Macías M, Lazalde-Ramos BP, Naranjo ME, Tarazona-Santos E, Llerena A; CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEFa.de Andrés F, et al.Drug Metabol Drug Interact. 2013;28(3):135-46. doi: 10.1515/dmdi-2013-0020.Drug Metabol Drug Interact. 2013.PMID: 23787463Review.
Llerena A, Dorado P, Ramírez R, Calzadilla LR, Peñas-Lledó E, Álvarez M, Naranjo ME, González I, Pérez B; CEIBA Consortium of Ibero–American Network of Pharmacogenetics & Pharmacogenomics RIBEF.Llerena A, et al.Pharmacogenomics. 2013 Dec;14(16):1973-7. doi: 10.2217/pgs.13.181.Pharmacogenomics. 2013.PMID: 24279852
Bedada W, de Andrés F, Engidawork E, Pohanka A, Beck O, Bertilsson L, Llerena A, Aklillu E.Bedada W, et al. Among authors: de andres f.J Clin Psychopharmacol. 2015 Dec;35(6):694-9. doi: 10.1097/JCP.0000000000000413.J Clin Psychopharmacol. 2015.PMID: 26444948
Fricke-Galindo I, Céspedes-Garro C, Rodrigues-Soares F, Naranjo ME, Delgado Á, de Andrés F, López-López M, Peñas-Lledó E, LLerena A.Fricke-Galindo I, et al. Among authors: de andres f.Pharmacogenomics J. 2016 Apr;16(2):113-23. doi: 10.1038/tpj.2015.70. Epub 2015 Oct 27.Pharmacogenomics J. 2016.PMID: 26503820Review.
Céspedes-Garro C, Fricke-Galindo I, Naranjo ME, Rodrigues-Soares F, Fariñas H, de Andrés F, López-López M, Peñas-Lledó EM, LLerena A.Céspedes-Garro C, et al. Among authors: de andres f.Expert Opin Drug Metab Toxicol. 2015;11(12):1893-905. doi: 10.1517/17425255.2015.1111871. Epub 2015 Nov 23.Expert Opin Drug Metab Toxicol. 2015.PMID: 26595139Review.
González-Vacarezza N, Alonso I, Arroyo G, Martínez J, De Andrés F, LLerena A, Estévez-Carrizo F.González-Vacarezza N, et al. Among authors: de andres f.Drug Metab Pers Ther. 2016 Jun 1;31(2):83-90. doi: 10.1515/dmpt-2015-0027.Drug Metab Pers Ther. 2016.PMID: 26974145Free article.Review.